Lexicon Pharmaceuticals (LXRX) Gains from Investment Securities: 2021-2024
Historic Gains from Investment Securities for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Dec 2024 value amounting to -$812,000.
- Lexicon Pharmaceuticals' Gains from Investment Securities rose 227.42% to $79,000 in Q3 2011 from the same period last year, while for Sep 2011 it was $32,000, marking a year-over-year change of. This contributed to the annual value of -$812,000 for FY2024, which is 46.30% up from last year.
- Latest data reveals that Lexicon Pharmaceuticals reported Gains from Investment Securities of -$812,000 as of FY2024, which was up 46.30% from -$1.5 million recorded in FY2023.
- Over the past 5 years, Lexicon Pharmaceuticals' Gains from Investment Securities peaked at $5.2 million during FY2022, and registered a low of -$1.5 million during FY2023.
- Its 3-year average for Gains from Investment Securities is $960,667, with a median of -$812,000 in 2024.
- Per our database at Business Quant, Lexicon Pharmaceuticals' Gains from Investment Securities spiked by 205.52% in 2022 and then crashed by 129.04% in 2023.
- Yearly analysis of 4 years shows Lexicon Pharmaceuticals' Gains from Investment Securities stood at $1.7 million in 2021, then spiked by 205.52% to $5.2 million in 2022, then tumbled by 129.04% to -$1.5 million in 2023, then skyrocketed by 46.30% to -$812,000 in 2024.